Dearborn Partners LLC lifted its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 6.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,406 shares of the company’s stock after buying an additional 433 shares during the quarter. Dearborn Partners LLC’s holdings in Colgate-Palmolive were worth $673,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the company. Swedbank AB lifted its stake in Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares during the period. Baker Avenue Asset Management LP lifted its position in Colgate-Palmolive by 10.9% during the third quarter. Baker Avenue Asset Management LP now owns 4,958 shares of the company’s stock valued at $515,000 after purchasing an additional 487 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Colgate-Palmolive in the third quarter worth approximately $109,000. Kennebec Savings Bank bought a new stake in Colgate-Palmolive in the 3rd quarter worth approximately $91,000. Finally, Catalytic Wealth RIA LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at $362,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently issued reports on CL. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Raymond James restated an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $101.61.
Colgate-Palmolive Price Performance
Shares of Colgate-Palmolive stock opened at $94.05 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The stock’s 50-day simple moving average is $89.03 and its 200-day simple moving average is $94.99. The company has a market capitalization of $76.32 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 4.20 and a beta of 0.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm posted $0.87 EPS. As a group, analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- 3 Healthcare Dividend Stocks to Buy
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Top Stocks Investing in 5G Technology
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What is the Euro STOXX 50 Index?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.